RelieVRx RVX-2022

GUDID 00850038247041

RelieVRx is an at-home immersive virtual reality (VR) pain treatment indicated as adjunctive treatment for chronic lower back pain (CLBP).

Appliedvr, Inc.

Pain relief virtual reality system

• Primary Device ID: 00850038247041
• NIH Device Record Key: 8e30c790-a166-4e7e-9bda-82cb66554272
• Commercial Distribution Status: In Commercial Distribution
• Brand Name: RelieVRx
• Version Model Number: RVX-2022
• Catalog Number: RVX-2022
• Company DUNS: 080429668
• Company Name: Appliedvr, Inc.
• Device Count: 1
• DM Exempt: false
• Pre-market Exempt: false
• MRI Safety Status: Labeling does not contain MRI Safety Information
• Human Cell/Tissue Product: false
• Device Kit: false
• Device Combination Product: false
• Single Use: false
• Lot Batch: false
• Serial Number: false
• Manufacturing Date: false
• Expiration Date: false
• Donation Id Number: false
• Contains Natural Rubber Latex: false
• Labeled No Natural Rubber Latex: false
• RX Perscription: true
• OTC Over-The-Counter: false

Customer Support Contacts

• Phone: (844) 728-4487
• Email: Support@AVRPathway.com
• Phone: (844) 728-4487
• Email: Support@AVRPathway.com
• Phone: (844) 728-4487
• Email: Support@AVRPathway.com
• Phone: (844) 728-4487
• Email: Support@AVRPathway.com
• Phone: (844) 728-4487
• Email: Support@AVRPathway.com
• Phone: (844) 728-4487
• Email: Support@AVRPathway.com
• Phone: (844) 728-4487
• Email: Support@AVRPathway.com
• Phone: (844) 728-4487
• Email: Support@AVRPathway.com
• Phone: (844) 728-4487
• Email: Support@AVRPathway.com
• Phone: (844) 728-4487
• Email: Support@AVRPathway.com
• Phone: (844) 728-4487
• Email: Support@AVRPathway.com
• Phone: (844) 728-4487
• Email: Support@AVRPathway.com
• Phone: (844) 728-4487
• Email: Support@AVRPathway.com
• Phone: (844) 728-4487
• Email: Support@AVRPathway.com
• Phone: (844) 728-4487
• Email: Support@AVRPathway.com
• Phone: (844) 728-4487
• Email: Support@AVRPathway.com
• Phone: (844) 728-4487
• Email: Support@AVRPathway.com

Device Identifiers

Device Issuing Agency	Device ID
GS1	00850038247041 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

• deNovo: DEN210014

FDA Product Code

• QRA: Virtual Reality Behavioral Therapy Device For Pain Relief

Sterilization

• Steralize Prior To Use: false
• Device Is Sterile: false

Device Entry Metadata

• Public Version Status: New
• Device Record Status: Published
• Public Version Number: 1
• Public Version Date: 2023-05-08
• Device Publish Date: 2023-04-28

On-Brand Devices [RelieVRx]

• 00850038247010: RelieVRx is an at-home immersive virtual reality (VR) pain treatment indicated as adjunctive tre
• 00850038247027: RelieVRx is an at-home immersive virtual reality (VR) pain treatment indicated as adjunctive tre
• 00850038247041: RelieVRx is an at-home immersive virtual reality (VR) pain treatment indicated as adjunctive tre
• 00850038247034: RelieVRx is an at-home immersive virtual reality (VR) pain treatment indicated as adjunctive tre
• 00850038247058: RelieVRx is an at-home immersive virtual reality (VR) pain treatment indicated as adjunctive tre
• 00850038247065: RelieVRx is an at-home immersive virtual reality (VR) pain treatment indicated as adjunctive tre
• 00850038247096: RelieVRx is an at-home immersive virtual reality (VR) pain treatment indicated as adjunctive tre
• 00850038247089: RelieVRx is an at-home immersive virtual reality (VR) pain treatment indicated as adjunctive tre
• 00850038247072: RelieVRx is an at-home immersive virtual reality (VR) pain treatment indicated as adjunctive tre
• 00850038247171: RelieVRx is an at-home immersive virtual reality (VR) pain treatment indicated as adjunctive tre
• 00850038247164: RelieVRx is an at-home immersive virtual reality (VR) pain treatment indicated as adjunctive tre
• 00850038247157: RelieVRx is an at-home immersive virtual reality (VR) pain treatment indicated as adjunctive tre
• 00850038247140: RelieVRx is an at-home immersive virtual reality (VR) pain treatment indicated as adjunctive tre